-
1
المؤلفون: Roberto Maisano, Giovanna Orizzonte, Giorgio Restifo, Pierpaolo Correale, Michele Caraglia, Vincenzo Dattola, Cirino Botta, Rita Agostino, Rita Emilena Saladino, Domenico Mazzacuva, Rocco Giannicola, Antonia Consuelo Falzea, Natale Daniele Calandruccio, Antonino Mafodda, Umberto Aguglia, Giovanna Bianco, Eleonora Iuliano, Vittoria Cianci
المساهمون: Botta, C., Agostino, R. M., Dattola, V., Cianci, V., Calandruccio, N. D., Bianco, G., Mafodda, A., Maisano, R., Iuliano, E., Orizzonte, G., Mazzacuva, D., Falzea, A. C., Saladino, R. E., Giannicola, R., Restifo, G., Aguglia, U., Caraglia, M., Correale, P., Botta C., Agostino R.M., Dattola V., Cianci V., Calandruccio N.D., Bianco G., Mafodda A., Maisano R., Iuliano E., Orizzonte G., Mazzacuva D., Falzea A.C., Saladino R.E., Giannicola R., Restifo G., Aguglia U., Caraglia M., Correale P.
المصدر: International Journal of Molecular Sciences, Vol 22, Iss 6246, p 6246 (2021)
International Journal of Molecular Sciencesمصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Case Report, Autoimmunity, Pembrolizumab, PD1-checkpoint inhibitors, medicine.disease_cause, 0302 clinical medicine, Antineoplastic Agents, Immunological, Biology (General), HLA Antigen, Myositi, PD1-checkpoint inhibitor, Spectroscopy, Myositis, General Medicine, Computer Science Applications, Myasthenia Gravi, Chemistry, Pyridostigmine, urothelial cancer, 030220 oncology & carcinogenesis, Urinary Bladder Neoplasm, Class-I/II HLA, Myasthenia, medicine.drug, Human, medicine.medical_specialty, QH301-705.5, Prognosi, Human leukocyte antigen, Antibodies, Monoclonal, Humanized, Catalysis, Inorganic Chemistry, 03 medical and health sciences, Internal medicine, medicine, Physical and Theoretical Chemistry, Adverse effect, Molecular Biology, QD1-999, Aged, business.industry, Organic Chemistry, Cancer, medicine.disease, Discontinuation, 030104 developmental biology, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3d5f1730fa5ddbbe610ba6d945569661Test
http://hdl.handle.net/11591/462420Test -
2
المؤلفون: Antonia Consuelo Falzea, Amalia Luce, Maria Antonietta Mazzei, Giovanna Bianco, Rocco Giannicola, Eleonora Iuliano, Iris Maria Forte, Daniele Caracciolo, Luigi Pirtoli, Pierosandro Tagliaferri, Alessandra Strangio, Michele Caraglia, Rita Emilena Saladino, Paolo Tini, Pierpaolo Pastina, Antonio Giordano, Pierpaolo Correale, Andrea Sergi, Valerio Nardone, Diana Giannarelli, Pierfrancesco Tassone, Natale Daniele Calandruccio, Luciano Mutti
المساهمون: Correale, P., Saladino, R. E., Giannarelli, D., Sergi, A., Mazzei, M. A., Bianco, G., Giannicola, R., Iuliano, E., Forte, I. M., Calandruccio, N. D., Falzea, A. C., Strangio, A., Nardone, V., Pastina, P., Tini, P., Luce, A., Caraglia, M., Caracciolo, D., Mutti, L., Tassone, P., Pirtoli, L., Giordano, A., Tagliaferri, P.
المصدر: Cells
Volume 9
Issue 9
Cells, Vol 9, Iss 1964, p 1964 (2020)مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, Genes, MHC Class I, immune-related pneumoniti, immune-related pneumonitis, Article, PD-1/PD-L1 blockade, 03 medical and health sciences, 0302 clinical medicine, Cancer immunotherapy, Internal medicine, irAE, medicine, Humans, Lung cancer, lcsh:QH301-705.5, Immune Checkpoint Inhibitors, Pneumonitis, Retrospective Studies, cancer immunotherapy, business.industry, Melanoma, HLA-profile, General Medicine, Pneumonia, Middle Aged, medicine.disease, Immune checkpoint, Blockade, Radiation therapy, 030104 developmental biology, lcsh:Biology (General), 030220 oncology & carcinogenesis, irAEs, Female, Immunotherapy, business, medicine.drug
وصف الملف: application/pdf
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5bc9c929bb077dbc57de3cfcdd247b02Test
http://europepmc.org/articles/PMC7564884Test -
3
المؤلفون: Nicoletta Staropoli, Pierfrancesco Tassone, Vito Barbieri, Angela Salvino, Pierosandro Tagliaferri, Domenico Ciliberto, Teresa Del Giudice, Francesco Grillone, Antonio Russo, Maria Cucè, Eleonora Iuliano
المساهمون: Staropoli, Nicoletta, Ciliberto, Domenico, Del Giudice, Teresa, Iuliano, Eleonora, Cucè, Maria, Grillone, Francesco, Salvino, Angela, Barbieri, Vito, Russo, Antonio, Tassone, Pierfrancesco, Tagliaferri, Pierosandro
مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, Settore MED/06 - Oncologia Medica, Poly (ADP-Ribose) Polymerase-1, Poly(ADP-ribose) Polymerase Inhibitors, law.invention, 03 medical and health sciences, 0302 clinical medicine, Randomized controlled trial, law, Ovarian cancer, Internal medicine, medicine, Humans, Meta-analysi, Progression-free survival, Adverse effect, Ovarian Neoplasms, business.industry, Hazard ratio, Hematology, Prognosis, Clinical trial, 030104 developmental biology, PARP inhibitor, 030220 oncology & carcinogenesis, Meta-analysis, Relative risk, Cohort, Female, Randomized clinical trial, Maintenance therapy, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce94b6b66d1bf4982c1662dd47dbf8acTest
http://hdl.handle.net/10447/298741Test -
4
المؤلفون: Vito Barbieri, Serafino Conforti, Eleonora Iuliano, Pierosandro Tagliaferri, Maria Teresa Di Martino, Cirino Botta, Francesca Scionti, Pietro Hiram Guzzi, Mariamena Arbitrio, Mario Cannataro, Stefania Codispoti, Pierfrancesco Tassone, Emanuela Altomare, Giuseppe Agapito
المساهمون: Arbitrio M., Di Martino M.T., Barbieri V., Agapito G., Guzzi P.H., Botta C., Iuliano E., Scionti F., Altomare E., Codispoti S., Conforti S., Cannataro M., Tassone P., Tagliaferri P.
المصدر: Cancer chemotherapy and pharmacology 77 (2016): 205–209. doi:10.1007/s00280-015-2916-3
info:cnr-pdr/source/autori:Arbitrio M.; Di Martino M.T.; Barbieri V.; Agapito G.; Guzzi P.H.; Botta C.; Iuliano E.; Scionti F.; Altomare E.; Codispoti S.; Conforti S.; Cannataro M.; Tassone P.; Tagliaferri P./titolo:Identification of polymorphic variants associated with erlotinib-related skin toxicity in advanced non-small cell lung cancer patients by DMET microarray analysis/doi:10.1007%2Fs00280-015-2916-3/rivista:Cancer chemotherapy and pharmacology/anno:2016/pagina_da:205/pagina_a:209/intervallo_pagine:205–209/volume:77مصطلحات موضوعية: 0301 basic medicine, Oncology, Male, Cancer Research, Lung Neoplasms, genetic structures, Microarray, Pharmacology, Toxicology, Skin rash, 0302 clinical medicine, Non-small cell lung cancer, Carcinoma, Non-Small-Cell Lung, Genotype, Pharmacology (medical), Erlotinib Hydrochloride, Cholecalciferol, Oligonucleotide Array Sequence Analysis, Middle Aged, Erlotinib, 030220 oncology & carcinogenesis, Female, Drug Eruptions, medicine.drug, medicine.medical_specialty, Single-nucleotide polymorphism, Antineoplastic Agents, Polymorphism, Single Nucleotide, 03 medical and health sciences, Internal medicine, medicine, Humans, Lung cancer, Aged, Retrospective Studies, 25-Hydroxyvitamin D3 1-alpha-Hydroxylase, Inflammation, business.industry, Microarray analysis techniques, Cancer, Single nucleotide polymorphisms, medicine.disease, Single nucleotide polymorphism, 030104 developmental biology, DMET, Quality of Life, business
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::017f396d53dbb9950317309f01f1b753Test
http://hdl.handle.net/10447/512516Test